# FDA Inspection 1023925 - Innovative Compounding Pharmacy - July 28, 2017

Source: https://www.keypedia.com/records/fda_inspections/innovative-compounding-pharmacy/b863af5c-fac7-46c9-ab0d-a42d8349f075
Source feed: FDA_Inspections

> FDA Inspection 1023925 for Innovative Compounding Pharmacy on July 28, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1023925
- Company Name: Innovative Compounding Pharmacy
- Inspection Date: 2017-07-28
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 922792 - 2015-04-17](https://www.keypedia.com/records/fda_inspections/innovative-compounding-pharmacy/2ae6828e-9448-46a3-a15f-a3c66cc4f433)

Company: https://www.keypedia.com/companies/innovative-compounding-pharmacy/22113e00-3e7e-47cf-9c38-2cc4063e7a4d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c